Life-Sciences-Europe.com
The European Life Sciences Web Portal

This is a free web portal for the life sciences in Europe and Israel... » read more

Innovative Molecules Raises €20m Series A Led by LSP (2021-06-07)
> Proceeds dedicated to advance Herpes simplex treatment IM-250 to Phase II > IM-250 demonstrates unprecedented impact on viral reservoir in preclinical studies Innovative Molecules GmbH, a German, Munich-based drug development company focused on developing...
Iksuda Closes $47m Round Led by Mirae Asset & Celltrion (2021-06-07)
> Funding to accelerate clinical progression of Iksuda’s pipeline of new generation of antibody drug conjugates, targeting tumours with high unmet need > Investment round led by Korean-based Mirae Asset Capital and Celltrion Iksuda Therapeutics (Iksuda), th...
Janssen Returns Global Rights to Cusatuzumab to Argenx (2021-06-07)
argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer, today announced it will regain worldwide rights to its anti-CD70 antibody cusatuzumab from Cilag GmbH I...
Amyl Therapeutics Closes €18.3m Series A Financing (2021-06-03)
Funds will be used to advance amyloid fibrils specific ClariTY technology platform as a potential best-in-class therapy for patients with Amyloidosis Amyl Therapeutics (‘Amyl’), a preclinical stage biotechnology company developing its amyloid fibrils specific ...
Exscientia Appoints Joanne Xu from SoftBank Board Director (2021-06-03)
> Joanne Xu is a Partner at SoftBank Investment Advisers with more than 20 years of investing and consulting experience in Asia > Fatou Bintou Sagnang, a Partner with Mubadala, is also joining as a Board Observer Exscientia the clinical stage, Artificial In...
ImaginAb $12.8m Financing Led by Adage Capital & Cycad Group (2021-06-03)
Latest financing will advance the clinical development of its CD8 ImmunoPET agent and build on its market leading position. ImaginAb Inc, a leading biotechnology company focused on developing next generation radiopharmaceutical imaging and therapy agents, has ...
Stablix Launches with $63m Series A Led by Versant Ventures (2021-06-03)
--Versant Ventures leads investment in first-in-category company with targeted protein stabilization platform -- --Foundational know-how establishes leadership in the field-- Stablix Therapeutics, a biotechnology company pioneering the field of Targeted Pro...
Transine Therapeutics Closes Extended £9.1m Seed Funding (2021-06-02)
New Company emerges from stealth with potential ground-breaking mRNA therapeutic platform to increase protein expression Transine Therapeutics (‘Transine’), a biotechnology company developing a novel class of therapeutic RNAs based on its pioneering SINEUP® pl...
MorphoSys to Acquire Constellation for $1.7b (2021-06-02)
> Accelerates Growth Strategy by Adding Two Mid- to Late-Stage Product Candidates: Pelabresib (CPI-0610) and CPI-0209 > Bolsters Position in Hematology-Oncology and Expands into Solid Tumors > Best-in-Class Combined Discovery and Development Capabilities Acc...
Gilde Healthcare: Joep Muijrers to Lead Public Investments (2021-06-02)
Seasoned investment expert in the life science sector with impressive track-record Gilde Healthcare, a specialized healthcare investor with €1.4 billion under management, today announced the appointment of Dr. Joep Muijrers to the investment team of its Ventur...

» Show all News!

Life-Sciences-Europe.com is your doorway to the European life sciences!

[LSE] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in Europe and Israel.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSE] is 100% Made in Germany!

» Start here with the latest News!

Picture EBD Group Connector Personal Networking in Life Sciences 650x80

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]